A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2002
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254143A2 Lipid-based drug delivery systems
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254118A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	EP1254104A1 Quaternary ammonium compounds and their use as anti-tussive agent
11/06/2002	EP1253923A1 Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0741577B1 The use of interferon subtype alpha 8 in the preparation of medicaments to treat viral infections of the liver
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases
11/06/2002	CN1378538A Diazocine-diketone derivatives and use as tryptase inhibitor thereof
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/06/2002	CN1378532A Substituted 1,5-dihydropyrrol-2-on derivatives as NMDA receptor antagonists for treatment of pain
11/06/2002	CN1378531A Substituted pyrolidine-2,3,4-trion-3-oxime derivatives useful as NMDA receptor antagonists
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1377705A Throat moistening carase tablet (sugar)
11/06/2002	CN1377670A Long life tea for curing various diseases
11/06/2002	CN1377667A Plaster for curing trachitis and its preparing method
11/06/2002	CN1377665A Decoction for treating nose and throat diseases
11/06/2002	CN1377661A Therapeutic liquid for common cold and rhinitis and its preparing method and use
11/06/2002	CN1377660A Medicine for curing bronchial asthma disease and its preparing method
11/06/2002	CN1377658A Liquid for eliminating phlegm and clearing away heat in pericardium
11/06/2002	CN1377641A Medicine for curing pneumoconiosis
11/06/2002	CN1377610A Health tea for throat
11/06/2002	CN1093852C 维生素ｄ酰胺衍生物 Amide derivatives of vitamin d
11/05/2002	US6476214 Inhibition of cytokine production
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476077 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
11/05/2002	US6476038 Amino substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476028 Compounds and methods
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
11/05/2002	US6476025 Phenylphennanthridines with PDE-IV inhibiting activity
11/05/2002	US6476023 Aromatic heterocyclic compounds as anti-inflammatory agents
11/05/2002	US6476022 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
11/05/2002	US6475997 Methods of stimulating phagocytosis
11/05/2002	US6475524 Composition of matter
11/05/2002	US6475509 Covalent conjugates of sodium channel blockers and active compounds
11/05/2002	US6475493 Controlled release pellet formulation
11/04/2002	WO2004001058A2 Transcription factor modulating compounds and methods of use thereof
10/2002
10/31/2002	WO2002086156A2 New polynucleotides and polypeptides of the ifn$g(a)-17 gene
10/31/2002	WO2002086113A2 Enzyme and snp marker for disease
10/31/2002	WO2002086085A2 Human timp-1 antibodies
10/31/2002	WO2002086069A2 Secreted proteins
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002	WO2002085925A2 Melanocortin receptor ligands
10/31/2002	WO2002085921A2 Simple method for the synthesis of boswellic acids and derivatives thereof
10/31/2002	WO2002085906A2 Phthalazinones derivatives useful as pde4/7 inhibitors
10/31/2002	WO2002085905A1 Novel adenine derivatives
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002085897A1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/31/2002	WO2002085894A1 Arylindenopyridines with pde inhibiting activity
10/31/2002	WO2002085888A1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
10/31/2002	WO2002085886A2 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
10/31/2002	WO2002085885A1 Piperazino-derivatives and their use as pde4 inhibitor
10/31/2002	WO2002085859A1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
10/31/2002	WO2002085855A1 2-iminopyrrolidine derivatives
10/31/2002	WO2002085850A1 Cyclic amidine derivative
10/31/2002	WO2002085412A1 Tissue fibrosis inhibitors
10/31/2002	WO2002085387A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions
10/31/2002	WO2002085386A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue
10/31/2002	WO2002085385A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa
10/31/2002	WO2002085384A2 Lubricious coatings for substrates
10/31/2002	WO2002085361A1 Benzimidazolone compounds
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	WO2002085354A1 Spiroindene and spiroindane compounds
10/31/2002	WO2002085338A2 Ipratropium formulation for pulmonary inhalation
10/31/2002	WO2002085309A2 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
10/31/2002	WO2002085308A2 Antisense and anti-inflammatory based compositions to treat respiratory disorders
10/31/2002	WO2002085299A2 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/31/2002	WO2002085296A2 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
10/31/2002	WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002	WO2002068390A8 Diamides which inhibit tryptase and factor xa activity
10/31/2002	WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002	WO2002064574A3 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
10/31/2002	WO2002053564A3 Quinuclidine derivatives and their use as m3 antagonists
10/31/2002	WO2002051356A3 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
10/31/2002	WO2002049650A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/31/2002	WO2002047700A9 Composite & making method of medicines for cold treatment
10/31/2002	WO2002043750A3 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
10/31/2002	WO2002041896A3 Use of thienopyrimidines
10/31/2002	WO2002040045A3 Microspheres of pancreatic enzymes with high stability
10/31/2002	WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	WO2002014499A3 Claudin polypeptides
10/31/2002	WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002	WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002	WO2001061356A9 Her-2 binding antagonists
10/31/2002	WO2001044243A3 Novel heteroaryl-diazabicycloalkanes

1 ... 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 ... 878